Literature DB >> 834142

Abnormal glucose tolerance in beta-thalassemia major.

C D Saudek, R M Hemm, C M Peterson.   

Abstract

The question of whether iron overload causes glucose intolerance was studied in a group of 26 multiply transfused homozygous beta thalassemics. Of the 26, 13 (50%) had some abnormality in their oral glucose tolerance test, 5 fitting criteria for definite diabetes. Glucose intolerance correlated significantly with number of transfusions received and with age of the subjects, while a positive family history for diabetes was more common in the subjects with glucose intolerance. These data and a chart review of four deceased thalassemics with overt diabetes are consistent with the following conclusions: (1) glucose intolerance is common in multiply transfused thalassemics; (2) the incidence of abnormal glucose tolerance correlates with the number of transfusions received and the age of the subject; (3) a family history of diabetes may predisose multiply transfused thalassemics to glucose intolerance.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 834142     DOI: 10.1016/0026-0495(77)90126-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  Insulin dependent diabetes in thalassaemia.

Authors:  V De Sanctis; M G Zurlo; E Senesi; C Boffa; L Cavallo; F Di Gregorio
Journal:  Arch Dis Child       Date:  1988-01       Impact factor: 3.791

Review 2.  Growth and endocrine function in thalassemia major in childhood and adolescence.

Authors:  M Delvecchio; L Cavallo
Journal:  J Endocrinol Invest       Date:  2010-01       Impact factor: 4.256

3.  Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus.

Authors:  S M Trigwell; P M Radford; S R Page; A C Loweth; R F James; N G Morgan; I Todd
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

4.  Three-year prospective evaluation of glucose tolerance, beta-cell function and peripheral insulin sensitivity in non-diabetic patients with thalassemia major.

Authors:  M F Messina; F Lombardo; A Meo; M Miceli; M Wasniewska; M Valenzise; C Ruggeri; T Arrigo; F De Luca
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

5.  The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study.

Authors:  J Rahier; S Loozen; R M Goebbels; M Abrahem
Journal:  Diabetologia       Date:  1987-01       Impact factor: 10.122

6.  Alpha and beta cell evaluation in patients with thalassaemia intermedia and iron overload.

Authors:  V De Sanctis; M R Gamberini; L Borgatti; G Atti; C Vullo; B Bagni
Journal:  Postgrad Med J       Date:  1985-11       Impact factor: 2.401

7.  The development of diabetes mellitus and chronic liver disease in long term chelated beta thalassaemic patients.

Authors:  V De Sanctis; G D'Ascola; B Wonke
Journal:  Postgrad Med J       Date:  1986-09       Impact factor: 2.401

8.  Insulin sensitivity and beta-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test.

Authors:  Holger Cario; Reinhard W Holl; Klaus-Michael Debatin; Elisabeth Kohne
Journal:  Eur J Pediatr       Date:  2003-01-15       Impact factor: 3.183

9.  The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Heba Elsedfy; Saif Al Yaarubi; Nicos Skordis; Doaa Khater; Mohamed El Kholy; Iva Stoeva; Bernadette Fiscina; Michael Angastiniotis; Shahina Daar; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-10-28       Impact factor: 2.576

10.  Detection of glycemic abnormalities in adolescents with beta thalassemia using continuous glucose monitoring and oral glucose tolerance in adolescents and young adults with β-thalassemia major: Pilot study.

Authors:  Ashraf T Soliman; Mohamed Yasin; Ahmed El-Awwa; Vincenzo De Sanctis
Journal:  Indian J Endocrinol Metab       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.